XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 323,227 $ 313,685
Marketable securities 142,287 151,687
Accounts receivable, net 86,995 104,530
Prepaid expenses and other current assets 14,155 14,878
Deferred contract costs, current 38,678 30,234
Total current assets 605,342 615,014
Property and equipment, net 5,485 7,012
Capitalized software, net 30,350 27,412
Operating lease right-of-use assets 8,620 11,377
Restricted cash, non-current 3,529 3,629
Deferred contract costs, non-current 35,174 35,411
Strategic investments 10,311 12,104
Intangible assets, net 7,197 9,331
Goodwill 12,646 12,646
Other assets 3,490 3,632
Total assets 722,144 737,568
Current liabilities:    
Accounts payable 5,314 14,529
Accrued expenses and other current liabilities 27,166 31,247
Content costs payable 37,105 37,310
Accrued compensation and benefits 21,520 22,882
Operating lease liabilities, current 7,081 7,002
Deferred revenue, current 285,346 273,937
Total current liabilities 383,532 386,907
Operating lease liabilities, non-current 3,282 6,545
Deferred revenue, non-current 2,179 4,342
Other liabilities, non-current 30 464
Total liabilities 389,023 398,258
Note 8 – Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.00001 par value - 50,000,000 shares authorized; zero shares issued and outstanding as of June 30, 2023, and December 31, 2022. 0 0
Common stock, $0.00001 par value - 950,000,000 shares authorized; 149,845,546 and 145,013,786 shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively. 1 1
Additional paid-in capital 1,015,851 951,946
Accumulated other comprehensive loss (48) (233)
Accumulated deficit (682,683) (612,404)
Total stockholders’ equity 333,121 339,310
Total liabilities and stockholders' equity $ 722,144 $ 737,568